Market Size of Europe Insulin Infusion Pumps Industry
| Study Period | 2018 - 2029 |
| Base Year For Estimation | 2023 |
| Market Size (2024) | USD 559.05 Million |
| Market Size (2029) | USD 675.26 Million |
| CAGR (2024 - 2029) | 3.85 % |
| Market Concentration | High |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Europe Insulin Infusion Pumps Market Analysis
The Europe Insulin Infusion Pumps Market size is estimated at USD 559.05 million in 2024, and is expected to reach USD 675.26 million by 2029, growing at a CAGR of 3.85% during the forecast period (2024-2029).
Over the past few years, Europe has observed a significant rise in its diabetic population, mirroring worldwide trends. Factors such as an aging demographic, shifts in lifestyle choices, and genetic factors have all played a role in the increasing prevalence of diabetes throughout Europe.
This surge affects both type 1 and type 2 diabetes, leading to a greater need for innovative technologies to effectively control the condition. An insulin pump (also known as continuous subcutaneous insulin therapy) is a medical device used for the administration of insulin in the treatment of diabetes. Insulin pumps make it possible to deliver continuous infusion amounts of insulin at regular intervals. This is predicted to result in long-term cost savings relative to multiple daily injections.
A conventional insulin pump includes the pump (including controls, a processing module, and batteries), a disposable reservoir for insulin (inside the pump), and a disposable infusion set, including a cannula for subcutaneous (under the skin) insertion and a tubing system to connect the insulin reservoir to the cannula. The configuration of the device may vary depending on the design. However, the application of infusion pumps across the world is increasing significantly.
Europe Insulin Infusion Pumps Industry Segmentation
An insulin pump might be a pleasant relief for diabetics who are sick of injecting themselves. A small, computerized device called an insulin pump can give insulin in one of two ways: either as a steady, measured, and continuous doze (known as "basal" insulin) or, at your request, as a surge ("bolus") doze just before meals. The European insulin infusion pump market is set to witness a CAGR of more than 4% during the forecast period. The European insulin infusion pump market is segmented by components and geography. The report offers the value (in USD) and volume (in units) for the above segments.
| Insulin Infusion Pump | |
| Insulin Pump Devices | |
| Insulin Infusion Sets | |
| Reservoirs |
| Geography | |
| France | |
| Germany | |
| Italy | |
| Spain | |
| United Kingdom | |
| Russia | |
| Rest of Europe |
Europe Insulin Infusion Pumps Market Size Summary
The Europe insulin infusion pumps market is experiencing a notable expansion, driven by the increasing prevalence of diabetes across the region. This rise is attributed to factors such as an aging population, lifestyle changes, and genetic predispositions, which have collectively heightened the demand for advanced diabetes management solutions. Insulin infusion pumps, which offer continuous subcutaneous insulin delivery, are becoming increasingly popular due to their potential for long-term cost savings compared to traditional multiple daily injections. The market is characterized by a variety of pump designs, including conventional pumps with external components and patch pumps that are worn directly on the body. The integration of continuous glucose monitoring (CGM) systems with insulin pumps is further enhancing their appeal, as these technologies work together to improve glycemic control and reduce the risk of severe hypoglycemia.
The market landscape in Europe is also shaped by significant healthcare expenditures related to diabetes, with a substantial portion of healthcare budgets allocated to managing the condition. Countries like Germany are witnessing a rise in diabetes cases, prompting advancements in insulin pump technology and reimbursement policies to support their adoption. Leading companies such as Medtronic, Roche, Ypsomed, Insulet, and Tandem are at the forefront of this market, with Medtronic maintaining a strong market position through innovative product offerings. Recent regulatory approvals, such as Medtronic's MiniMed 780G pump and Insulet's Omnipod 5 system, highlight the ongoing technological advancements and regulatory support that are expected to drive market growth in the coming years.
Europe Insulin Infusion Pumps Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Drivers
-
1.3 Restraints
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Bargaining Power of Suppliers
-
1.4.2 Bargaining Power of Consumers
-
1.4.3 Threat of New Entrants
-
1.4.4 Threat of Substitute Products and Services
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 Insulin Infusion Pump
-
2.1.1 Insulin Pump Devices
-
2.1.2 Insulin Infusion Sets
-
2.1.3 Reservoirs
-
-
2.2 Geography
-
2.2.1 France
-
2.2.2 Germany
-
2.2.3 Italy
-
2.2.4 Spain
-
2.2.5 United Kingdom
-
2.2.6 Russia
-
2.2.7 Rest of Europe
-
-
Europe Insulin Infusion Pumps Market Size FAQs
How big is the Europe Insulin Infusion Pumps Market?
The Europe Insulin Infusion Pumps Market size is expected to reach USD 559.05 million in 2024 and grow at a CAGR of 3.85% to reach USD 675.26 million by 2029.
What is the current Europe Insulin Infusion Pumps Market size?
In 2024, the Europe Insulin Infusion Pumps Market size is expected to reach USD 559.05 million.
